Tarsons Products Ltd

AI
Tarsons Products Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Tarsons Products Ltd

₹ 336 -0.28%
04 Sep - close price
tarsons.com BSE: 543399 NSE: TARSONS
About

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]

Key Points

Business Profile:[1]
Tarson is a labware company engaged
in designing, development, manufacturing
and marketing of consumables, reusables
and others (including benchtop equipment & instruments)

Website BSE NSE
  • Market Cap ₹ 1,785 Cr.
  • Current Price ₹ 336
  • High / Low ₹ 375 / 164
  • Stock P/E 86.6
  • Book Value ₹ 127
  • Dividend Yield 0.00 %
  • ROCE 5.66 %
  • ROE 3.54 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 2.64 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 7.78% over past five years.
  • Company has a low return on equity of 6.20% over last 3 years.
  • Dividend payout has been low at 6.92% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
62.57 66.32 61.79 86.64 64.85 80.12 76.16 93.04 71.28 80.51 83.99 97.16 86.15
41.27 40.94 38.90 52.77 47.83 56.62 48.24 56.07 49.05 54.37 54.85 64.59 61.98
Operating Profit 21.30 25.38 22.89 33.87 17.02 23.50 27.92 36.97 22.23 26.14 29.14 32.57 24.17
OPM % 34.04% 38.27% 37.04% 39.09% 26.25% 29.33% 36.66% 39.74% 31.19% 32.47% 34.69% 33.52% 28.06%
2.26 2.60 3.38 5.93 4.86 10.65 2.12 6.37 4.58 7.32 8.36 7.64 6.75
Interest 2.41 0.95 2.51 4.08 4.20 4.68 4.13 4.52 4.28 4.41 5.32 5.41 5.44
Depreciation 8.30 9.71 10.06 10.21 8.96 11.96 15.61 17.48 17.75 20.17 22.65 26.70 24.56
Profit before tax 12.85 17.32 13.70 25.51 8.72 17.51 10.30 21.34 4.78 8.88 9.53 8.10 0.92
Tax % 25.29% 26.10% 26.42% 26.34% 25.80% 26.21% 26.12% 26.34% 25.10% 26.46% 25.60% 32.59% 26.09%
9.60 12.80 10.07 18.78 6.46 12.93 7.61 15.73 3.57 6.53 7.09 5.46 0.68
EPS in Rs 1.80 2.41 1.89 3.53 1.21 2.43 1.43 2.96 0.67 1.23 1.33 1.03 0.13
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
179 176 229 301 283 277 314 333 348
107 107 125 148 153 174 209 223 236
Operating Profit 72 69 103 153 130 103 105 110 112
OPM % 40% 39% 45% 51% 46% 37% 34% 33% 32%
6 4 5 8 12 14 24 28 30
Interest 7 6 3 4 4 10 18 19 21
Depreciation 15 14 14 22 29 38 54 87 94
Profit before tax 56 53 92 135 109 69 58 31 27
Tax % 30% 24% 25% 25% 26% 26% 26% 28%
39 41 69 101 81 51 43 23 20
EPS in Rs 2,027.06 2,108.74 3,583.25 18.92 15.17 9.63 8.03 4.26 3.72
Dividend Payout % 0% 0% 0% 0% 0% 21% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 8%
3 Years: 6%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: -19%
3 Years: -34%
TTM: -48%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -14%
1 Year: 5%
Return on Equity
10 Years: %
5 Years: 11%
3 Years: 6%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.19 0.20 0.19 11 11 11 11 11
Reserves 135 197 244 479 559 610 642 665
65 36 34 22 111 257 231 274
12 15 18 33 46 76 107 152
Total Liabilities 212 249 296 544 726 953 991 1,102
89 92 120 189 225 252 460 661
CWIP 7 19 22 32 119 267 233 159
Investments 0 0 0 0 0 0 13 44
116 137 153 323 382 434 285 238
Total Assets 212 249 296 544 726 953 991 1,102

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
51 64 68 83 76 105 110 112
-34 -26 -64 -138 -179 -296 -52 -138
-18 -14 -27 130 85 136 -54 25
Net Cash Flow -0 25 -23 75 -18 -55 4 -1
Free Cash Flow 18 38 6 -48 -113 -79 -42 -14
CFO/OP 95% 115% 89% 77% 77% 119% 120% 109%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 91 79 75 79 85 94 86 85
Inventory Days 333 365 277 478 642 528 419 387
Days Payable 14 44 35 75 54 42 36 48
Cash Conversion Cycle 409 400 317 482 672 580 469 423
Working Capital Days 86 110 108 150 166 -24 37 -30
ROCE % 27% 37% 35% 19% 10% 9% 6%

Insights

In beta
Mar 2019 Mar 2020 Jun 2021 Mar 2023 Mar 2024 Mar 2025 Mar 2026
ODM Share of Export Revenue
%

Log in to view insights

Please log in to see hidden values.

Login
Product Mix - Consumables Revenue Share
%
Product Mix - Reusables Revenue Share
%
Domestic Distributors
count
Number of Manufacturing Facilities
count
Number of Product Segments
count
Number of SKUs
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

30 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.30% 47.30% 47.30%
7.85% 6.83% 8.16% 7.95% 8.04% 7.51% 9.53% 9.14% 5.82% 2.46% 0.87% 0.15%
3.15% 2.60% 0.17% 0.11% 0.21% 0.51% 0.30% 0.04% 0.08% 0.00% 0.19% 0.10%
41.68% 43.27% 44.36% 44.63% 44.45% 44.69% 42.89% 43.50% 46.79% 50.23% 51.65% 52.44%
No. of Shareholders 1,08,2361,07,5641,02,8661,05,33099,58696,92793,41790,89188,96687,33684,09383,453

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls